What question did this study set out to answer?

The aim is to investigate advancements in nanodrug delivery systems for effective glaucoma therapy.

May 20, 2026BiomedicinesOpen Access

Advancements in Nanodrug Delivery Systems as Controlled-Release Systems for Glaucoma Therapy: An Inspirational Step Toward Translation from Research to Clinic

View Full Paper

Ask AI

Bookmark

Authors

Review evaluates controlled-release nanodrug systems to manage glaucoma, suggesting improved clinical translation.

The aim is to investigate advancements in nanodrug delivery systems for effective glaucoma therapy.
Evaluation of various nanocarriers such as nanoparticles, micelles, liposomes, and nanofibers.
Focus on systems achieving over 12 hours of drug release.
Assessment of the advantages and disadvantages of each delivery system.
Substantial improvements in ocular barrier-crossing capabilities and bioavailability were observed.
Prolonged drug release and effective targeting of active tissues reduced intraocular pressure.
Potential for successful translation from research to clinical applications was highlighted.

Hosseinkhani et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark